HuangLabMcGill
@HuangLabMcGill
Followers
190
Following
38
Media
3
Statuses
25
Functional genomics to uncover druggable vulnerabilities in cancer. @McGillBiochem, @McGillGCI, @mcgillu
Montréal, Québec
Joined September 2018
Congrats Yibo Xue, Jordan Morris & Connie Yang! Their int'l study published in @NatureComms from the labs of Dr Huang (@HuangLabMcGill) at the GCI & Dr Prudent (@LabPrudent) at @MRC_MBU @Cambridge_Uni sheds new light on aggressive cancers. > https://t.co/9ySS3JhlTE
#cancerresearch
2
4
24
Excited to share our study with @LabPrudent linking SMARCA4/2 to Ca2+ flux in controlling chemotherapy response published in Nature Communications. Congrats to Yibo Xue, Jordan Morris & Kangning Yang in our labs for driving this great collaborative effort!
8
11
48
A fantastic mentor. I am extremely grateful for all of her guidance and support!
Today on #InternationalDayOfWomenInScience we're celebrating our beloved Director, Dr Morag Park, a research leader in #breastcancer who's inspiring her almost-all female lab team to become future leaders too! 👏🏻👏🏻👏🏻 https://t.co/nSgeQa0w1U
@McGillFamMed @McGillREPORTER #Cancer
0
2
15
Seeking for a PDF for a joint project with Dr. William Foulkes https://t.co/wO1vEAKyvt
sidonghuanglab.com
0
2
1
Félicitations aux personnes admises ou promues à l’Ordre national du Québec, dont le Dr Phil Gold et le Pr Philippe Gros, les Drs Daniel Borsuk et Laurent Duvernay-Tardif, diplômés mcgillois, et la philanthrope Sharon Azrieli. Suite : https://t.co/2qsEEZLm84
@mcgillu #McGillMed
0
1
3
At the Defi Canderel race (30 years and going strong!) with the GCRC running and volunteers. Raising money for cancer research! @McGillGCRC @DefiCanderel
2
2
26
TIME/LOCATION CHNAGE Re: Rene Bernards - GCRC annual lecture, May 3rd. Due to his multiple flight delays. Lecture now at 2pm today, Karp Amphitheater, Room 501, Goodman Cancer Research Centre 1160 Pine Ave W, Montreal, QC H3A 1A3
1
0
1
Research from the @HuangLabMcGill shows that SMARCA4 loss in non-small cell lung cancer reduces cyclin D levels and provides a therapeutic opportunity for Cdk4/6 inhibitors https://t.co/2ikROx4LNu
#cancerresearch @McGillGCRC
0
4
7
Deux articles de chercheurs de @mcgillu publiés simultanément dans @NatureComms donnent à penser qu’un médicament utilisé contre le cancer du sein ER positif pourrait être efficace contre deux autres types de cancer. #JournéeMondialeContreLeCancer https://t.co/gqYxN9QHdw
1
5
8
Our 2 B2B papers are finally out @NatureComms! Yibo Xue et al uncovered an unexpected vulnerability common in ovarian and lung cancers - SMARCA4 loss results in cyclin D1 deficiency leading to susceptibility to CDK4/6 inhibitors. https://t.co/Tp2sAcrVYT
https://t.co/w4v1WydIDw
3
2
19